Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)

10.1371/journal.pone.0006811

Saved in:
Bibliographic Details
Main Authors: Dickhaut K., Hoepner S., Eckhard J., Wiesmueller K.-H., Schindler L., Jung G., Falk K., Roetzschke O.
Other Authors: MICROBIOLOGY AND IMMUNOLOGY
Format: Article
Published: 2019
Subjects:
Mus
Online Access:https://scholarbank.nus.edu.sg/handle/10635/161829
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-161829
record_format dspace
spelling sg-nus-scholar.10635-1618292024-03-27T08:17:59Z Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE) Dickhaut K. Hoepner S. Eckhard J. Wiesmueller K.-H. Schindler L. Jung G. Falk K. Roetzschke O. MICROBIOLOGY AND IMMUNOLOGY adamantane HLA DR antigen HLA DR1 antigen HLA DR4 antigen major histocompatibility antigen major histocompatibility antigen class 2 NY ESO 1 antigen tumor antigen cancer vaccine HLA antigen class 2 subunit vaccine animal cell animal experiment animal model antibody combining site antigen presenting cell article catalysis CD4+ T lymphocyte controlled study dendritic cell immune response in vivo study Influenza virus ligand binding mouse nonhuman transgenic mouse animal Bagg albino mouse cell proliferation cell separation chemistry CpG island human immunology immunotherapy methodology neoplasm tumor cell line Murinae Mus Orthomyxoviridae Animals Cancer Vaccines CD4-Positive T-Lymphocytes Cell Line, Tumor Cell Proliferation Cell Separation CpG Islands Histocompatibility Antigens Class II Humans Immunotherapy Mice Mice, Inbred BALB C Mice, Transgenic Neoplasms Vaccines, Subunit 10.1371/journal.pone.0006811 PLoS ONE 4 9 e6811 2019-11-07T08:16:42Z 2019-11-07T08:16:42Z 2009 Article Dickhaut K., Hoepner S., Eckhard J., Wiesmueller K.-H., Schindler L., Jung G., Falk K., Roetzschke O. (2009). Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE). PLoS ONE 4 (9) : e6811. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0006811 19326203 https://scholarbank.nus.edu.sg/handle/10635/161829 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20191101
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic adamantane
HLA DR antigen
HLA DR1 antigen
HLA DR4 antigen
major histocompatibility antigen
major histocompatibility antigen class 2
NY ESO 1 antigen
tumor antigen
cancer vaccine
HLA antigen class 2
subunit vaccine
animal cell
animal experiment
animal model
antibody combining site
antigen presenting cell
article
catalysis
CD4+ T lymphocyte
controlled study
dendritic cell
immune response
in vivo study
Influenza virus
ligand binding
mouse
nonhuman
transgenic mouse
animal
Bagg albino mouse
cell proliferation
cell separation
chemistry
CpG island
human
immunology
immunotherapy
methodology
neoplasm
tumor cell line
Murinae
Mus
Orthomyxoviridae
Animals
Cancer Vaccines
CD4-Positive T-Lymphocytes
Cell Line, Tumor
Cell Proliferation
Cell Separation
CpG Islands
Histocompatibility Antigens Class II
Humans
Immunotherapy
Mice
Mice, Inbred BALB C
Mice, Transgenic
Neoplasms
Vaccines, Subunit
spellingShingle adamantane
HLA DR antigen
HLA DR1 antigen
HLA DR4 antigen
major histocompatibility antigen
major histocompatibility antigen class 2
NY ESO 1 antigen
tumor antigen
cancer vaccine
HLA antigen class 2
subunit vaccine
animal cell
animal experiment
animal model
antibody combining site
antigen presenting cell
article
catalysis
CD4+ T lymphocyte
controlled study
dendritic cell
immune response
in vivo study
Influenza virus
ligand binding
mouse
nonhuman
transgenic mouse
animal
Bagg albino mouse
cell proliferation
cell separation
chemistry
CpG island
human
immunology
immunotherapy
methodology
neoplasm
tumor cell line
Murinae
Mus
Orthomyxoviridae
Animals
Cancer Vaccines
CD4-Positive T-Lymphocytes
Cell Line, Tumor
Cell Proliferation
Cell Separation
CpG Islands
Histocompatibility Antigens Class II
Humans
Immunotherapy
Mice
Mice, Inbred BALB C
Mice, Transgenic
Neoplasms
Vaccines, Subunit
Dickhaut K.
Hoepner S.
Eckhard J.
Wiesmueller K.-H.
Schindler L.
Jung G.
Falk K.
Roetzschke O.
Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)
description 10.1371/journal.pone.0006811
author2 MICROBIOLOGY AND IMMUNOLOGY
author_facet MICROBIOLOGY AND IMMUNOLOGY
Dickhaut K.
Hoepner S.
Eckhard J.
Wiesmueller K.-H.
Schindler L.
Jung G.
Falk K.
Roetzschke O.
format Article
author Dickhaut K.
Hoepner S.
Eckhard J.
Wiesmueller K.-H.
Schindler L.
Jung G.
Falk K.
Roetzschke O.
author_sort Dickhaut K.
title Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)
title_short Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)
title_full Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)
title_fullStr Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)
title_full_unstemmed Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)
title_sort enhancement of tumour-specific immune responses in vivo by 'mhc loading-enhancer' (mle)
publishDate 2019
url https://scholarbank.nus.edu.sg/handle/10635/161829
_version_ 1795300781209944064